Clinical Trial UCI-15-99 Click to view printable page


Open-label, non-randomized, phase 2 study evaluating efficacy and safety of PQR309 in patients with relapsed or refractory primary CNS lymphoma

Principal Investigator

Daniela Bota


Learn More

For information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email

If you would like more information regarding this specific trial, please leave your name, phone number, and email. We will contact you promptly.

Name: Email: Phone: